PAIOF Stock UPDATES Paion Ag Aachen (PAIOF) 3.2100 09/18/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Paion Ag Aachen (PAIOF) 3.2100 $PAIOF

Radiation Toxicity Pipeline Review (Radiation Sickness, Acute Radiation Syndrome) - 2013 Edition
M2 - Mon Jun 24, 4:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3jc3b4/radiation) has announced the addition of the "Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H1 2013" report to their offering. This research provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for radiation toxicity , complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for radiation toxicity. The report is built using data and information sourced from proprietary databases, company/university websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Key Topics Covered: 1. List of Tables/Figures 2. Introduction 2.1 Global Markets Direct Report Coverage 3. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Overvi

Hemophilia - Pipeline Review, H1 2013
M2 - Fri Apr 05, 6:51AM CDT
Research and Markets (http://www.researchandmarkets.com/research/89nnlh/hemophilia) has announced the addition of the "Hemophilia - Pipeline Review, H1 2013" report to their offering. 'Hemophilia - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Hemophilia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hemophilia. Reasons to buy - Identify and understand important and diverse types of therapeutics under development for Hemophilia. - Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage. - Plan mergers and acquisitions effectively by identifying players of the most promising pipeline. - Devise corrective measures for pipeline projects by understanding Hemophilia pipeline depth and focus of Indicatio

Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H1 2013
M2 - Mon Mar 25, 9:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/xpq2c2/radiation) has announced the addition of the "Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H1 2013" report to their offering. Global Markets Direct's, 'Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome). Scope - A snapshot of the global therapeutic scenario for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome). - A review of the Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) products under develo




Scroll down for more posts ▼

Top 10 Most Recent News Articles

The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 3

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 8

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 4

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading
Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 2

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 3

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 3

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading
Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 3

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 3

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 4

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading

Top 5 Most Recently Viewed Articles

Credit Blockchain Unveils Innovative AI Platform for Digital Growth

Updated Category News Views 127

Introducing Credit Blockchain's Cutting-Edge AI Platform Credit Blockchain has rolled out a groundbreaking AI-powered computing platform that stands to reshape the blockchain landscape. As a leader in decentralized technology, the company continues to bring innovation to the forefront, merging artificial intelligence with clean energy solutions to create a more...

Continue Reading
International Battery Metals Successfully Joins OTCQB Venture Market

Updated Category News Views 106

International Battery Metals Uplisting to OTCQB Venture Market International Battery Metals Ltd. ("IBAT" or the "Company") has reached an important milestone by successfully uplisting to the OTCQB Venture Market, trading under the ticker symbol "IBATF". This encouraging development showcases the Company’s compliance with the rigorous listing qualifications mandated by...

Continue Reading
Man Group PLC’s Disclosure on American Axle & Manufacturing

Updated Category News Views 150

Key Information on Position Disclosure FORM 8.3: PUBLIC OPENING POSITION DISCLOSURE This disclosure is for individuals or entities holding a significant interest in securities, representing 1% or more, in accordance with the regulatory framework set in place. Details of the Discloser 1. Who is Disclosing? Man Group PLC has made the disclosure regarding its interests in...

Continue Reading
MSA Safety to Host Its First Quarter Earnings Call Soon

Updated Category News Views 160

MSA Safety Announces Upcoming Earnings Conference Call MSA Safety Incorporated (NYSE: MSA), a leading name in the safety products industry, will host its first quarter earnings conference call on a scheduled date. This event signals an important communication opportunity for investors and stakeholders eager to learn about the company's performance and future aspirations....

Continue Reading
Transformative Growth: A Deep Dive into Cheniere Energy's Success

Updated Category News Views 177

An Insight into Cheniere Energy's Phenomenal Growth Cheniere Energy (NYSE: LNG) has emerged as a prominent player in the energy sector, showcasing remarkable growth over the past 15 years. This period has seen the company consistently outperform the market, achieving an impressive annualized return of 32.6%, which equates to a staggering outperformance of 20.85% compared...

Continue Reading